Wednesday, October 8, 2014
Sesi CME : "Optimizing the treatment of advanced EGFR Mutant NSCLC - The Rationale of Gefitinib in First Line Setting"
TARIKH : 15 OKTOBER 2014 ( RABU)
MASA : 12.00 - 1.00 PETANG
TEMPAT : BILIK MESYUARAT DELIMA, BPF
PENCERAMAH : DR MASTURA
ANJURAN : ASTRAZENECA (M) SDN BHD
MATA CPD : A4 (1 MATA)
SEMUA DIJEMPUT HADIR.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment